Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07779616
Recruiting
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Phase 2 · Georgia, Mauritius, United States, South Africa · 26 sites
Registry update: 6 Nov 2026
NCT07792954
Recruiting
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Phase 3 · China · 34 sites
Registry update: 5 Nov 2026
NCT07504588
Recruiting
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
Phase 2 · United States · 22 sites
Registry update: 5 Nov 2026
NCT06962176
Recruiting
Posterior Mitral Isthmus Line With Vein of Marshall Ethanolisation Compared With Anterior Mitral Lines in Patients With Persistent Atrial Fibrillation
Not applicable · Belgium · 1 site
Registry update: 26 Oct 2026
NCT07733349
Recruiting
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
Phase 1/2 · China · 1 site
Registry update: 4 Nov 2026
NCT07506863
Recruiting
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
Phase 3 · Greece, Italy, United States · 8 sites
Registry update: 29 Oct 2026
NCT07856199
Recruiting
Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease
Not applicable · Mexico · 1 site
Registry update: 2 Oct 2026
2025-523896-44-00
Recruiting
Efanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining
Phase 3 · Austria, Germany · 16 sites
Registry update: 27 Oct 2026
NCT07475949
Recruiting
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
Phase 3 · China · 15 sites
Registry update: 30 Sept 2026
NCT05652478
Recruiting
Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
Phase 2 · United States · 1 site
Registry update: 29 Sept 2026
NCT07716449
Recruiting
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ
Phase 3 · China · 1 site
Registry update: 19 Oct 2026
NCT07700979
Recruiting
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Phase 3 · China, Germany, Poland, United States · 25 sites
Registry update: 29 Sept 2026
NCT07816666
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Phase 3 · Australia, Brazil, Canada, China, Germany, Spain, India, Italy, Japan, South Korea, Thailand, Taiwan, United States · 108 sites
Registry update: 16 Oct 2026
NCT07813429
Recruiting
Changes in Cervical Posture, Cervical Function, and Neck Pain After Sleeve Gastrectomy
Not applicable · 1 site
Registry update: 28 Sept 2026
NCT07684599
Recruiting
A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)
Phase 3 · Canada, Japan, South Korea · 12 sites
Registry update: 3 Nov 2026
NCT07860047
Recruiting
Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer
Phase 2 · Germany · 4 sites
Registry update: 6 Oct 2026
NCT07735637
Recruiting
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Phase 3 · Australia, Brazil, Canada, China, Germany, Denmark, Spain, France, United Kingdom, Italy, Japan, South Korea, Norway, Poland, Saudi Arabia, Singapore, Taiwan, United States · 97 sites
Registry update: 21 Oct 2026
NCT07799116
Recruiting
Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis
Phase 1/2 · Spain · 8 sites
Registry update: 1 Oct 2026
NCT07789769
Recruiting
A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)
Not applicable · United States · 3 sites
Registry update: 5 Oct 2026
2025-522659-24-00
Recruiting
OVACURE-2
Phase 1/2 · Netherlands · 1 site
Registry update: 3 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.